Vol. 44 No. 16
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
SparingVision doses first patient in NYRVANA clinical trial of SPVN20 for retinitis pigmentosa
2
Eli Lilly to acquire Adverum Biotechnologies
3
Regeneron receives another CRL for its Eylea 8 mg
4
Anti-VEGF innovations in retinal disease: From molecules to medicine
5
.png "Optometry Times"){kind=logo}
